Search Results 1041-1050 of 18362 for Hepatitis C

1. A Study to Evaluate Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant - Mayo Clinic

   Known active bacterial, viral (e.g. HIV, hepatitis B, hepatitis C), fungal, mycobacterial, or other infection (including tuberculosis or atypical ...

2. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   The atezolizumab plus interferon alfa-2b arm (Arm B), plus pegylated interferon alfa-2a (PEG−interferon alfa-2a, Arm C) ... Participants with active hepatitis C ...

3. Digestive Diseases Calculators - Medical Professionals - Mayo Clinic

   MELD Score and 90-Day Mortality Rate for Alcoholic Hepatitis ...

4. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Positive for hepatitis B, hepatitis C or HIV infection; Pregnant or lactating women or women who intend to become pregnant within the period of time of this ...

5. A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM - Mayo Clinic

   ... Hepatitis C (e.g., Hepatitis C Virus [HCV] RNA [qualitative] is detected). Untreated or unsuccessfully treated Hepatitis B or C. Participating Mayo Clinic ...

6. Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155) - Mayo Clinic

   Has a known history of or is positive for hepatitis B (hepatitis B surface antigen reactive) or hepatitis C (hepatitis C virus RNA [qualitative] is detected) ...

7. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT) - Mayo Clinic

   Active hepatitis B or C infection. Note: A detailed assessment of Hepatitis B/C medical history and risk factors must be done at screening for all patients.

8. To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea. - Mayo Clinic

   A positive Hepatitis B surface antigen or Hepatitis C test result. History of immunodeficiency diseases, including a positive HIV (ELISA and Western blot) ...

9. Head and neck cancers - Doctors and departments - Mayo Clinic

   Displaying 1-10 out of 11 doctors available. Last Name Initial: C,C,C,C,C,C,C,C. William J. Casey, III, M.D.. Plastic Surgeon.

10. Adverse effects related to Heplisav-B vaccination in patients with Inflammatory Bowel Disease - Mayo Clinic

    Immunity to Hepatitis B through vaccination in patients with inflammatory bowel disease and chronic liver disease is crucial due to high risk of morbidity. Part ...